4940 studies found for:    stem cell
Show Display Options
Rank Status Study
41 Recruiting Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Leukemia;   Lymphoma;   Allogeneic Haematopoietic Stem Cell Transplantation;   Acute Lymphoblastic Leukemia
Interventions: Drug: Busulfan;   Drug: Clofarabine;   Drug: Thymoglobulin;   Procedure: Stem Cell Transplant
42 Recruiting Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Conditions: Stem Cell Transplantation;   Leukemia;   Lymphoma
Interventions: Drug: Thiotepa;   Drug: Clofarabine;   Drug: Busulfan;   Procedure: Allogeneic Stem Cell Transplantation;   Drug: Thymoglobulin (ATG);   Drug: G-CSF (Filgrastim);   Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Cyclophosphamide;   Drug: Mesna
43 Active, not recruiting Intravenous Stem Cells After Ischemic Stroke
Conditions: Ischemia;   Stroke
Intervention: Genetic: Autologous mesenchymal stem cells
44 Completed Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome
Condition: Limbus Corneae Insufficiency Syndrome
Intervention: Procedure: Stem Cell with Amniotic Membrane Transplant
45 Recruiting Dose-Intensive Chemotherapy in Combination With Chemoprotected Autologous Stem Cells in Treating Patients With Malignant Gliomas
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Radiation: Radiation Therapy;   Biological: Filgrastim;   Drug: Plerixafor;   Drug: Carmustine;   Drug: Temozolomide;   Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: O6-Benzylguanine;   Other: Laboratory Biomarker Analysis
46 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
47 Recruiting Stem Cell Ophthalmology Treatment Study
Conditions: Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
Interventions: Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
48 Completed Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia
Condition: Diabetic Foot
Interventions: Biological: tissue repair cells (TRC);   Biological: bone marrow stem cells (BMC)
49 Completed Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: Thymoglobulin;   Drug: Azacitidine;   Procedure: Stem Cell Transplant
50 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
Condition: Acute Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
51 Completed
Has Results
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Plerixafor;   Drug: Filgrastim;   Drug: Fludarabine;   Drug: Busulfan;   Procedure: Allogeneic blood stem cell transplant;   Drug: ATG (Thymoglobulin)
52 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease
Condition: Chronic Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
53 Recruiting To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients
Condition: Renal Transplant Rejection
Intervention: Biological: Mesenchymal Stem Cells
54 Terminated
Has Results
Stem Cell Transplantation for Children Affected With Osteopetrosis
Condition: Osteopetrosis
Interventions: Procedure: Stem Cell Transplantation;   Device: Miltenyi Biotec CliniMACS;   Drug: Systemic chemotherapy and antibodies
55 Terminated
Has Results
Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
Conditions: ALL;   ANLL;   MDS;   NHL
Interventions: Procedure: Naive T-cell Depleted Stem Cell Transplant;   Procedure: Stem Cell Transplant No Manipulation;   Device: Isolex device from Baxter
56 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Interventions: Biological: Autologous Stem Cell Transplant;   Biological: Allogeneic Stem Cell Transplant
57 Unknown  IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
Conditions: Heart Failure;   Heart Attack;   Coronary Artery Bypass Surgery
Intervention: Biological: Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting
58 Enrolling by invitation The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: stem cell transplantation
59 Active, not recruiting Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
Conditions: Diffuse Large Cell Lymphoma;   Lymphoma
Interventions: Drug: Zevalin;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Rituximab;   Procedure: Stem Cell Transplant
60 Terminated Stem Cell Transplant for Hematologic Diseases
Condition: Hematologic Malignancies
Interventions: Biological: Campath 1H;   Drug: Fludarabine;   Procedure: Stem Cell Transplant;   Radiation: Total Body Irradiation (TBI);   Drug: FK506 (Tacrolimus) or Cyclosporine

First Page    Show previous page of results Previous Page (21-40) Studies Shown (41-60) Next Page (61-80) Show next page of results    Last Page
Indicates status has not been verified in more than two years